|Day Low/High||14.00 / 14.05|
|52 Wk Low/High||8.28 / 16.15|
The tech company's shares climb on strong sales of the iPhone in Europe.
AtheroGenics was up and Affymetrix was down in an uneven market for health care stocks.
Investors in Sirna, Illumina and Celgene can count their blessings this Thanksgiving.
Momentum may wane a bit, but the days surrounding Thanksgiving may return us to the upside.
Affymetrix climbs after beating Street estimates, despite a third-quarter loss.
PeopleSupport and Altiris post stronger-than-expected second-quarter results.
Its efficient genome-sequencing technology will put the company on the map.
Affymetrix is burned after its first-quarter results miss both its own and Wall Street's targets.
Discovery Labs drops after the FDA issues more requirements for the approval of its Surfaxin drug.
Google's I.V. hit 26%, and Neurocrine Biosciences and Affymetrix spiked as well.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.